BioSpace News Archive

Parkinson’s disease affects the brain’s nerve cells that produce dopamine. Researchers at the University of Helsinki have identified a molecule called BT13 that potentially can increase levels of dopamine.

Long-term data boosts the efficacy of Bristol-Myers Squibb’s checkpoint inhibitor, Opdivo, as a treatment for renal cell carcinoma.

The BioSpace Ideal Employer Report examined aspects regarding the importance of culture within life sciences organizations.

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion is interested in how social media affects the public’s perception of drugs.

The U.S. Food and Drug Administration accepted the companies’ New Drug Application for lurbinectedin under Priority Review.

Brain eating amoeba treatment is crucial in the current world as infections are rising. Moreover, it is very deadly, killing about 97% of infected patients.

When you’re ready for a new job, contacting employers is a no-brainer. But the same kind of clear-cut call to action doesn’t necessarily apply to contacting recruiters.

Read on for tips on how to handle a difficult co-worker you just can’t get along with.

New sites to recruit voluntary military personnel in ongoing Phase 2 study in Sudden Sensorineural Hearing Loss

MINNEAPOLIS , Feb. 17, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel , Chief Financial Officer, will present at the SVB Leerink 9 th Annual Global Healthcare Conference on Wednesday, February 26, 2020 at 11:30 a.m. EST . The conference will be held at the Lotte New York Palace in New York, NY . A live webcast of the presentatio